Oscar Slotboom

Oscar Slotboom is the Managing Partner at BioGeneration Ventures, with a background that includes roles such as Chief Commercial Officer at Avantium and BU Head of Vaccines and Infectious Diseases at Crucell China/Xian Janssen. He has invested in notable companies like CatalYm and NorthSea Therapeutics, demonstrating expertise in Series A and C investments in the pharmaceutical and biotech sectors. Slotboom's career highlights include leading successful investments in companies like VarmX and Mellon Medical, showcasing his ability to drive growth and commercialization strategies in the health and biopharmaceutical industries. His current role as Managing Partner at BioGeneration Ventures reflects his strong leadership in due diligence, business development, and cross-functional team management within the life sciences sector.